Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Am J Obstet Gynecol. 2020 Aug 11;223(5):727.e1–727.e11. doi: 10.1016/j.ajog.2020.08.006

Table 2:

OAB-q* subscale scores between baseline and follow-up

Baseline Follow-up Change Post - Pre p-value
OAB-q* subscales, median (IQR**)
Symptom severity 48 (43–70) 25 (8–50) −23 (−38– −5) <0.001
Coping 65 (43–83) 88 (75–100) 18 (3–38) <0.001
Concern 57 (37–71) 86 (57–97) 23 (6–34) <0.001
Sleeping 64 (32–76) 84 (60–92) 16 (0–24) <0.001
Social 92 (80–100) 100 (95–100) 4 (0–16) 0.006
HRQOL*** 67 (46–78) 86 (71–97) 17 (6–27) <0.001
*

OAB-q: Overactive Bladder quantified

**

IQR: interquartile range

***

HRQOL: Health Related Quality of Life

bold: statistically significant, p<0.05